Showing results (361-370 of 428) with videos related to

Sort By:
Pageof 43
Annals of the Rheumatic Diseases|August 4, 2023
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trialAbdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, et al.
Annals of the Rheumatic Diseases|February 19, 2016
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationCarina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, et al.
Autoimmunity Reviews|October 27, 2010
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritisMartina Fabris, Luca Quartuccio, Sandra Lombardi, et al.
Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patientsImane Abouyahya, Sophie I E Liem, Zahir Amoura, et al.
Rheumatology (Oxford, England)|March 8, 2021
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill countLinda Hartman, Maurizio Cutolo, Reinhard Bos, et al.
Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Arthritis Research & Therapy|April 3, 2016
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS surveyRoberta Ramonda, Antonio Marchesoni, Antonio Carletto, et al.
Autoimmunity Reviews|January 4, 2015
State of the art: Reproduction and pregnancy in rheumatic diseasesMonika Østensen, Laura Andreoli, Antonio Brucato, et al.
Annals of the Rheumatic Diseases|May 31, 2022
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trialMaarten Boers, Linda Hartman, Daniela Opris-Belinski, et al.
Pageof 43